172 related articles for article (PubMed ID: 12795734)
21. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
[TBL] [Abstract][Full Text] [Related]
22. Does access to a colorectal cancer screening website and/or a nurse-managed telephone help line provided to patients by their family physician increase fecal occult blood test uptake?: results from a pragmatic cluster randomized controlled trial.
Clouston K; Katz A; Martens PJ; Sisler J; Turner D; Lobchuk M; McClement S; Crow G;
BMC Cancer; 2014 Apr; 14():263. PubMed ID: 24739235
[TBL] [Abstract][Full Text] [Related]
23. Lack of follow-up after fecal occult blood testing in older adults: inappropriate screening or failure to follow up?
Carlson CM; Kirby KA; Casadei MA; Partin MR; Kistler CE; Walter LC
Arch Intern Med; 2011 Feb; 171(3):249-56. PubMed ID: 20937917
[TBL] [Abstract][Full Text] [Related]
24. Colorectal cancer screening with double-contrast barium enema: a national survey of diagnostic radiologists.
Klabunde CN; Jones E; Brown ML; Davis WW
AJR Am J Roentgenol; 2002 Dec; 179(6):1419-27. PubMed ID: 12438029
[TBL] [Abstract][Full Text] [Related]
25. Fecal occult blood testing beliefs and practices of U.S. primary care physicians: serious deviations from evidence-based recommendations.
Nadel MR; Berkowitz Z; Klabunde CN; Smith RA; Coughlin SS; White MC
J Gen Intern Med; 2010 Aug; 25(8):833-9. PubMed ID: 20383599
[TBL] [Abstract][Full Text] [Related]
26. Physician barriers to population-based, fecal occult blood test-based colorectal cancer screening programs for average-risk patients.
McGregor S; Hilsden R; Yang H
Can J Gastroenterol; 2010 Jun; 24(6):359-64. PubMed ID: 20559577
[TBL] [Abstract][Full Text] [Related]
27. Physician recommendations for follow-up of positive fecal occult blood tests.
Yabroff KR; Klabunde CN; Myers R; Brown ML
Med Care Res Rev; 2005 Feb; 62(1):79-110. PubMed ID: 15643030
[TBL] [Abstract][Full Text] [Related]
28. Colorectal cancer screening using the faecal occult blood test (FOBt): a survey of GP attitudes and practices in the UK.
Damery S; Clifford S; Wilson S
BMC Fam Pract; 2010 Mar; 11():20. PubMed ID: 20214769
[TBL] [Abstract][Full Text] [Related]
29. Equity and practice issues in colorectal cancer screening: Mixed-methods study.
Buchman S; Rozmovits L; Glazier RH
Can Fam Physician; 2016 Apr; 62(4):e186-93. PubMed ID: 27618142
[TBL] [Abstract][Full Text] [Related]
30. Contribution of patient, physician, and environmental factors to demographic and health variation in colonoscopy follow-up for abnormal colorectal cancer screening test results.
Partin MR; Gravely AA; Burgess JF; Haggstrom DA; Lillie SE; Nelson DB; Nugent SM; Shaukat A; Sultan S; Walter LC; Burgess DJ
Cancer; 2017 Sep; 123(18):3502-3512. PubMed ID: 28493543
[TBL] [Abstract][Full Text] [Related]
31. Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004-2008.
Choi KS; Lee HY; Jun JK; Shin A; Park EC
J Gastroenterol Hepatol; 2012 Jun; 27(6):1070-7. PubMed ID: 22004224
[TBL] [Abstract][Full Text] [Related]
32. Colorectal cancer screening behavior in women attending screening mammography: longitudinal trends and predictors.
Carlos RC; Fendrick AM; Abrahamse PH; Dong Q; Patterson SK; Bernstein SJ
Womens Health Issues; 2005; 15(6):249-57. PubMed ID: 16325138
[TBL] [Abstract][Full Text] [Related]
33. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
[TBL] [Abstract][Full Text] [Related]
34. Association of ten gastrointestinal and other medical conditions with positivity to faecal occult blood testing in routine screening: a large prospective study of women in England.
He E; Alison R; Blanks R; Pirie K; Reeves G; Ward RL; Steele R; Patnick J; Canfell K; Beral V; Green J
Int J Epidemiol; 2019 Apr; 48(2):549-558. PubMed ID: 30668711
[TBL] [Abstract][Full Text] [Related]
35. Physicians' use of nonphysician healthcare providers for colorectal cancer screening.
Sansbury LB; Klabunde CN; Mysliwiec P; Brown ML
Am J Prev Med; 2003 Oct; 25(3):179-86. PubMed ID: 14507523
[TBL] [Abstract][Full Text] [Related]
36. Colorectal cancer screening in asymptomaic adults: comparison of colonoscopy, sigmoidoscopy and fecal occult blood tests.
Cheng TI; Wong JM; Hong CF; Cheng SH; Cheng TJ; Shieh MJ; Lin YM; Tso CY; Huang AT
J Formos Med Assoc; 2002 Oct; 101(10):685-90. PubMed ID: 12517041
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic testing following fecal occult blood screening in the elderly.
Lurie JD; Welch HG
J Natl Cancer Inst; 1999 Oct; 91(19):1641-6. PubMed ID: 10511591
[TBL] [Abstract][Full Text] [Related]
38. Would general practitioners support a population-based colorectal cancer screening programme of faecal-occult blood testing?
Tong S; Hughes K; Oldenburg B; Del Mar C
Intern Med J; 2004; 34(9-10):532-8. PubMed ID: 15482265
[TBL] [Abstract][Full Text] [Related]
39. Levels and variation in overuse of fecal occult blood testing in the Veterans Health Administration.
Partin MR; Powell AA; Bangerter A; Halek K; Burgess JF; Fisher DA; Nelson DB
J Gen Intern Med; 2012 Dec; 27(12):1618-25. PubMed ID: 22810358
[TBL] [Abstract][Full Text] [Related]
40. Using a multifaceted approach to improve the follow-up of positive fecal occult blood test results.
Singh H; Kadiyala H; Bhagwath G; Shethia A; El-Serag H; Walder A; Velez ME; Petersen LA
Am J Gastroenterol; 2009 Apr; 104(4):942-52. PubMed ID: 19293786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
